NGS Made Effortless: Introducing MIRO CANVAS from INTEGRA Biosciences

September 22, 2023 04:03 AM AEST | By EIN Presswire

Google News:

NGS Made Effortless: Introducing MIRO CANVAS from INTEGRA Biosciences — Image source: EIN Presswire

Recent News

What are next big copper projects? UBS tells when equipment makers cou...

EUR/USD poised to rack up more gains as ECB and Fed rate paths set to...

Carney launches ‘One Canadian Economy’ Act to unify trade, approvals

Trump signs orders to enhance drone defenses, support supersonic trave...

CAMBRIDGESHIRE, UK, September 21, 2023 /EINPresswire.com/ -- INTEGRA Biosciences is excited to announce the launch of MIRO CANVAS, a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. The revolutionary system drastically simplifies NGS workflows for more walk-away time and higher lab productivity, accelerating genomics discoveries.

NGS has made it possible to sequence entire genomes at a fraction of the cost and time of earlier sequencing methods. However, sample and library preparation for NGS workflows still remain a challenge, as they are notoriously complex, time consuming and error prone when performed manually.

MIRO CANVAS was developed to meet the growing need for fully automated NGS sample preparation with verified protocols for short- and long-read sequencing applications to ensure accuracy, precision and reliability for high quality results. The microfluidics system uses gentle sample handling to maintain the integrity of high molecular weight DNA and minimizes reagent usage for long-read sequencing library preparation. MIRO CANVAS can also automate exome and other hybrid capture protocols, one of the most laborious protocols in NGS sample preparation.

The intuitive platform requires only 15 minutes of hands-on time per run, freeing up researchers to work on other vital tasks in the lab. It also offers fast, on-demand preparation of samples, so clinical specimens can be processed straight away upon receipt – without the need for batching – streamlining genomics workflows.

“The addition of the MIRO CANVAS system to our portfolio represents a significant milestone for INTEGRA,” said Urs Hartmann, CEO of INTEGRA Biosciences. “The innovative microfluidics platform streamlines NGS workflows and will open up completely new application areas for researchers, helping to advance scientific discoveries in the field of genomics.”

Visit the INTEGRA Biosciences website to learn more.

About INTEGRA Biosciences

INTEGRA Biosciences (https://www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.

Emily Armiger-Welch
kdm communications limited
+44 1480 405333
[email protected]

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.